Latest Adult attention deficit hyperactivity disorder Stories
LONDON, April 1, 2015 /PRNewswire/ -- ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations Summary
ATLANTA, April 1, 2015 /PRNewswire-USNewswire/ -- The first national study to look at behavioral therapy, medication, and dietary supplements to treat attention-deficit/hyperactivity disorder
NEW YORK, Nov. 24, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alcobra Ltd ("Alcobra" or the "Company") (NASDAQ: ADHD).
Neurovance, Inc. today announced complete results from its phase 2a pilot study of EB-1020 SR, a non-stimulant, in adult male patients with all subtypes of ADHD (attention deficit hyperactivity disorder).
SAN FRANCISCO, February 4, 2014 /PRNewswire/ -- - 36 out of 47 adult subjects (77%) completed the double-blind placebo controlled,
A first-of-its-kind double-blind study shows “statistically robust improvements” in adult ADHD using a specialized multivitamin-mineral treatment. Raymond,
Up to two-thirds of children with attention deficit/hyperactivity disorder (ADHD) find their disorder persists into adulthood yet only a small proportion of adults ever receive a formal diagnosis and treatment, research suggests.
RnRMarketResearch.com adds Latest Report on “ADHD Therapeutics Market to 2018” to its store. Dallas, Texas (PRWEB) June 06, 2013 The impending publication